Kalincik, TomasHorakova, DanaSpelman, TimJokubaitis, VilijaTrojano, MariaLugaresi, AlessandraIzquierdo, GuillermoRózsa, CsillaGrammond, PierreAlroughani, RaedDuquette, PierreGirard, MarcPucci, EugenioLechner-Scott, JeannetteSlee, MarkFernandez-Bolanos, RicardoGrand'Maison, FrancoisHupperts, RaymondVerheul, FreekHodgkinson, SuzanneOreja-Guevara, CeliaSpitaleri, DanieleBarnett, MichaelTerzi, MuratBergamaschi, RobertoMcCombe, PamelaSanchez-Menoyo, JoseSimó, MagdolnaCsépány, TündeRum, GáborBoz, CavitHavrdova, EvaButzkueven, Helmut2015-04-072015-04-072015Annals Of Neurology. -77 : 3 (2015), p. 425-435. -Ann. Neurol. - 0364-51340364-5134http://hdl.handle.net/2437/208839Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosisfolyóiratcikkopen access pre-print és post-printhttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM058152OrvostudományokKlinikai orvostudományokhttp://doi.wiley.com/10.1002/ana.24339Wileyhttp://dx.doi.org/10.1002/ana.24339122017-12-01